| 摘要 |
Disclosed is an anti-IL-23p19 antibody or antigen-binding fragment thereof, wherein the antibody or antigen-binding fragment thereof comprises the heavy and light chains with the CDRs as disclosed in the specification. Also disclosed is a method for producing the antibody and its use in the treatment of an inflammatory disease, of an autoimmune disease, of a respiratory disease, of a metabolic disorder or of cancer. |
